WHO ICTRP trial
Clinical study of cryoablation combined with immune checkpoint inhibitors in the…
ChiCTR2100050931 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2100050931 |
|---|---|
| Public title | Clinical study of cryoablation combined with immune checkpoint inhibitors in the treatment of solid tumors |
| Scientific title | Clinical study of cryoablation combined with immune checkpoint inhibitors in the treatment of solid tumors |
| Primary sponsor | Fujian Medical University Union Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Solid tumors |
| Interventions | Control group:cryoablation;Experimental group:cryoablation + PD-1 monoclonal antibody therapy |
| Registration date | Sep 8, 2021 |
| Target size | Control group:32;Experimental group:32 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: